drugset / Trial / NCT07314281
Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever
RandomizedParallel-groupOpen-labelTreatment
Summary
1. Primary Objective: o To evaluate the efficacy of intravenous azithromycin compared with meropenem in the treatment of extensively drug-resistant (XDR) enteric fever. 2. Secondary Objectives: * To evaluate the fever defervescence and Salmonella Typhi eradication * To evaluate the cost-effectiveness of intravenous azithromycin versus meropenem in treating XDR enteric fever. 3. Exploratory Objectives: * To evaluate the drug resistance against intravenous azithromycin versus in treating XDR enteric fever.
Timeline
- Start
- 2025-04-22
- Primary completion
- 2027-01-15
- Completion
- 2027-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 500 mg | Intravenous |
| Comparator | Meropenem | Small molecule | 1000 mg | Intravenous |